Postpartum Care Support for Gestational Diabetes and Hypertension
Trial Summary
What is the purpose of this trial?
STEP-UP will promote linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior gestational diabetes mellitus (GDM) and/or hypertensive disorders of pregnancy (HDP).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment OB Provider Clinical Decision Support (CDS), Patient Education, and other components for postpartum care in gestational diabetes and hypertension?
Research shows that using educational toolkits and quality improvement initiatives can improve prenatal education and screening rates for gestational diabetes, although postpartum care still needs better coordination. Additionally, patient navigation and virtual connections in prenatal care models have been effective in improving care coordination and patient engagement, which could be beneficial for postpartum care.12345
Is the postpartum care support for gestational diabetes and hypertension generally safe for humans?
How does this treatment for postpartum care support in gestational diabetes and hypertension differ from other treatments?
This treatment is unique because it focuses on improving postpartum care through educational toolkits and quality improvement initiatives, which aim to enhance clinical practices and increase follow-up visits and screenings for type 2 diabetes in women with a history of gestational diabetes. Unlike standard treatments that may not emphasize postpartum follow-up, this approach seeks to improve coordination between prenatal and postpartum care providers.110111213
Research Team
Stacy Bailey, PhD MPH
Principal Investigator
Northwestern University
Eligibility Criteria
The STEP-UP trial is for postpartum women over 18 who had gestational diabetes or hypertension during pregnancy. Participants must have attended a prenatal care visit at a study site within the last 6 months and speak English or Spanish.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
STEP-UP intervention promoting linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior GDM and/or HDP
Follow-up
Participants are monitored for completion of primary care visits and dysglycemia testing
Treatment Details
Interventions
- OB Provider Clinical Decision Support (CDS) (Behavioral Intervention)
- Patient Education (OB Visit) (Behavioral Intervention)
- Patient Education (Primary Care Visit) (Behavioral Intervention)
- Patient Outreach (Behavioral Intervention)
- Primary Care Provider Clinical Decision Support (CDS) (Behavioral Intervention)
- Text messaging (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Dr. Jeffrey Sherman
Northwestern University
Chief Medical Officer
MD from Northwestern University
Dr. Alicia Löffler
Northwestern University
Chief Executive Officer since 2010
PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech
AllianceChicago
Collaborator
Cook County Health
Collaborator